Andrea Necchi, One Oncology Madrid Program Director of Quirónsalud, Adjunct Professor at The University of Texas MD Anderson Cancer Center, shared on X:
“First announcement of the 5th Ospedale San Raffaele Annual GU Oncology Retreat | Milan, December 4, 2026.
It marks the most Internationally attended GU Oncology meeting of our Country. The family of friends and supporting partners is growing fast. Key discussion topic this year is the future of clinical research in EU.”
To which Petros Grivas, Clinical Director of the GU Cancer Program at the University of Washington, added:
“Congrats Andrea Necchi, Ospedale San Raffaele, Alberto Briganti and Francesco Montorsi for a phenomenal annual meeting!”
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, also shared on X:
“My session during GU Rounds in Nashville.
We’re arguing adjuvant in RCC, MRD, and post-IO sequencing in kidney cancer, reviewing the exciting data from Litespark-022 and Litespark-011 and nobody at the table fully agrees. Medical oncologist, radiation oncologist, and urologist from academics to community practice sharing thoughts.
Exactly the point.”
Katy Beckermann also added:
“Closing the night on prostate. From high risk localized disease discussion of best treatment options surgery vs radiation… To the mHSPC question that keeps coming up: who do you intensify, and who can you spare?
Biomarkers are starting to answer it.
GU Rounds expertly led by K. Schaffer with input from the entire Nashville team”
Other articles about GU Oncology on OncoDaily.
